Heart positive: Design of a randomized controlled clinical trial of intensive lifestyle intervention, niacin and fenofibrate for HIV lipodystrophy/dyslipidemia-Reference-Cited by-同舟云学术

Heart positive: Design of a randomized controlled clinical trial of intensive lifestyle intervention, niacin and fenofibrate for HIV lipodystrophy/dyslipidemia

Published:2006-12 Issue:6 Volume:27 Page:518-530
ISSN:1551-7144
Container-title:Contemporary Clinical Trials
language:en
Short-container-title:Contemporary Clinical Trials

Author:

Samson Susan L.,Pownall Henry J.,Scott Lynne W.,Ballantyne Christie M.,Smith E. O'Brian,Sekhar Rajagopal V.,Balasubramanyam Ashok

Publisher

Elsevier BV

Subject

Pharmacology (medical),General Medicine

Reference55 articles.

1. Antiretroviral therapy-associated hyperlipidaemia in HIV disease;Mooser;Curr Opin Lipidol,2001

2. Cardiovascular disease risk factors in HIV-infected patients in the HAART era;Galli;Ann N Y Acad Sci,2001

3. Insulin resistance in the HIV-lipodystrophy syndrome;Grinspoon;Trends Endocrinol Metab,2001

4. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study;Castelli;JAMA,1986

5. Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S;Ballantyne;Circulation,2001

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fatty liver in lipodystrophy: A review with a focus on therapeutic perspectives of adiponectin and/or leptin replacement;Metabolism;2019-07

2. Niacin for primary and secondary prevention of cardiovascular events;Cochrane Database of Systematic Reviews;2017-06-14

3. Fenofibrate in cancer: mechanisms involved in anticancer activity;F1000Research;2015-07-07

4. Fenofibrate in cancer: mechanisms involved in anticancer activity;F1000Research;2015-02-26

5. Managing dyslipidemia in HIV/AIDS patients: challenges and solutions;HIV/AIDS - Research and Palliative Care;2014-12